probenecid has been researched along with Calcium Pyrophosphate Deposition Disease in 6 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gout and calcium pyrophosphate deposition disease are two common causes of inflammatory joint disease." | 2.43 | An update on the treatment options for gout and calcium pyrophosphate deposition. ( Choy, G, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Announ, N | 1 |
| Guerne, PA | 1 |
| Choy, G | 1 |
| Rosenthal, AK | 1 |
| Ryan, LM | 1 |
| Smith, EE | 1 |
| Dixon, A | 1 |
| Wolfe, F | 1 |
| Cathey, MA | 1 |
| McCarty, DJ | 1 |
3 reviews available for probenecid and Calcium Pyrophosphate Deposition Disease
| Article | Year |
|---|---|
Treating difficult crystal pyrophosphate dihydrate deposition disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcium Pyrophosphate; Chondrocal | 2008 |
An update on the treatment options for gout and calcium pyrophosphate deposition.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Allopurinol; Animals; Anti-Inflammatory Agents | 2005 |
Crystal deposition joint disease.
Topics: Aged; Arthritis, Rheumatoid; Chondrocalcinosis; Colchicine; Crystallization; Diphosphates; Female; G | 1974 |
1 trial available for probenecid and Calcium Pyrophosphate Deposition Disease
| Article | Year |
|---|---|
Letter: Probenecid in chondrocalcinosis articularis.
Topics: Chondrocalcinosis; Drug Evaluation; Humans; Probenecid | 1976 |
2 other studies available for probenecid and Calcium Pyrophosphate Deposition Disease
| Article | Year |
|---|---|
Probenecid inhibits transforming growth factor-beta 1 induced pyrophosphate elaboration by chondrocytes.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Cartilage, Articular; Chondrocalcinosis; Diphosphates; Knee Jo | 1994 |
The misdiagnosis of gout and hyperuricemia.
Topics: Adult; Aged; Allopurinol; Analysis of Variance; Arthritis, Psoriatic; Chondrocalcinosis; Colchicine; | 1991 |